IBO logo

Impact BioMedical NYSEAM:IBO Stock Report

Last Price

US$2.51

Market Cap

US$28.9m

7D

-10.7%

1Y

n/a

Updated

20 Nov, 2024

Data

Company Financials

Impact BioMedical Inc.

NYSEAM:IBO Stock Report

Market Cap: US$28.9m

IBO Stock Overview

Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. More details

IBO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health2/6
Dividends0/6

Impact BioMedical Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Impact BioMedical
Historical stock prices
Current Share PriceUS$2.51
52 Week HighUS$3.25
52 Week LowUS$1.22
Beta0
11 Month Change96.09%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-6.34%

Recent News & Updates

Recent updates

Shareholder Returns

IBOUS PharmaceuticalsUS Market
7D-10.7%-5.3%-1.2%
1Yn/a8.7%30.4%

Return vs Industry: Insufficient data to determine how IBO performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how IBO performed against the US Market.

Price Volatility

Is IBO's price volatile compared to industry and market?
IBO volatility
IBO Average Weekly Movement23.0%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.1%

Stable Share Price: IBO's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine IBO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20181Frank Heuszelwww.impactbiomedinc.com

Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances.

Impact BioMedical Inc. Fundamentals Summary

How do Impact BioMedical's earnings and revenue compare to its market cap?
IBO fundamental statistics
Market capUS$28.87m
Earnings (TTM)US$1.17m
Revenue (TTM)n/a

24.8x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IBO income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other Expenses-US$1.16m
EarningsUS$1.17m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.10
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio23.3%

How did IBO perform over the long term?

See historical performance and comparison